180 related articles for article (PubMed ID: 7002122)
21. Examination of the anti-anginous effect of Sensit in angina pectoris.
Tóth K
Ther Hung; 1986; 34(4):212-6. PubMed ID: 3449975
[No Abstract] [Full Text] [Related]
22. [Fendiline for hypodynamic coronary heart disease patients. Calmodulin antagonists--alternatives to calcium antagonism].
Fortschr Med; 1985 Oct; 103(40):64. PubMed ID: 4065792
[No Abstract] [Full Text] [Related]
23. [Hemodynamic and humoral effects of fendiline, a calcium antagonist drug, in idiopathic hypertension patients].
Castellano M; Beschi M; Muiesan ML; Romanelli G; Muiesan G
Cardiologia; 1984; 29(7-8):359-66. PubMed ID: 6542415
[No Abstract] [Full Text] [Related]
24. [Value of fendiline in the treatment of patients with stable angina pectoris].
Markiewicz M; Wysokiński A; Rymar B; Trojnar R
Pol Tyg Lek; 1987 Nov; 42(46):1456-8. PubMed ID: 3328180
[No Abstract] [Full Text] [Related]
25. [Study of the action of fenalcomine chlorhydrate using ergometric tests].
Quiret JC; Lesbre JP; Bernasconi P
Ann Cardiol Angeiol (Paris); 1975; 24(3):285-7. PubMed ID: 1096749
[No Abstract] [Full Text] [Related]
26. [Effect of heparin on the physical loading tolerance of chronic coronary insufficiency patients].
Kucheriavyĭ PG; Terno VS; Taktuk EE
Vrach Delo; 1981 Sep; (9):39-41. PubMed ID: 7303609
[No Abstract] [Full Text] [Related]
27. [Effect of the calcium antagonist fendiline on digitalis-induced ischemic reactions in the ECG].
Kababgi MD; Schneider KW; Deeg P
Med Welt; 1980 Jun; 31(25):959-62. PubMed ID: 7421525
[No Abstract] [Full Text] [Related]
28. [Evaluation of the calcium antagonist fendilin in exertion angina].
Fino E; Colonna L
Clin Ter; 1985 Mar; 112(5):445-51. PubMed ID: 3893860
[No Abstract] [Full Text] [Related]
29. Clinical application of Sensit.
Pálossy B
Ther Hung; 1981; 29(4):171-5. PubMed ID: 6765146
[No Abstract] [Full Text] [Related]
30. Effect of Sensit (fendiline) in angina pectoris.
Böszörményi E; Ludvigh K; Fehér G; Schwarz J; Kármán M; Sziebert P
Ther Hung; 1981; 29(3):134-7. PubMed ID: 7188139
[No Abstract] [Full Text] [Related]
31. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808
[No Abstract] [Full Text] [Related]
32. [Effect of fendiline on left-ventricular function evaluated by the echocardiographic method and on physical work capacity of patients with stable angina pectoris].
Markiewicz M; Wysokiński A; Rymar B; Trojnar R; Wójcik J; Sokoluk I
Wiad Lek; 1987 Dec; 40(24):1664-8. PubMed ID: 3451600
[No Abstract] [Full Text] [Related]
33. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
Furkalo NK; Zaĭtseva VI
Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
[No Abstract] [Full Text] [Related]
34. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
[No Abstract] [Full Text] [Related]
35. [Tolerance to physical exercise in patients with chronic coronary insufficiency treated with anticoagulants].
Gritsiuk AI; Kucheriavyĭ PG; Terno VS
Ter Arkh; 1982; 54(3):49-51. PubMed ID: 7089886
[No Abstract] [Full Text] [Related]
36. [Evaluation of a multicenter study on the new coronary vasodilator agent Sensit].
Meza E; Orozco-Mafud A
Prensa Med Mex; 1977; 42(1-2):78-83. PubMed ID: 331301
[No Abstract] [Full Text] [Related]
37. Fendiline: a review of its basic pharmacological and clinical properties.
Bayer R; Mannhold R
Pharmatherapeutica; 1987; 5(2):103-36. PubMed ID: 3310016
[TBL] [Abstract][Full Text] [Related]
38. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
Oliveira JM
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
[No Abstract] [Full Text] [Related]
39. [The effect of fendilin-hydrochloride (Sensit) in the ergometric test in patients with coronary disease].
Streicher KA; Guckenbiehl W; Olbermann W
Med Welt; 1976 Jul; 27(29):1295-7. PubMed ID: 957963
[No Abstract] [Full Text] [Related]
40. [Polygraphic and electrocardiographic study of a new coronary therapeutic agent: dilazep].
Parenti B; Selvaggi R
Clin Ter; 1980 Jan; 92(2):155-63. PubMed ID: 7389275
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
